Spots Global Cancer Trial Database for Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer
Official Title:
Study ID: NCT02843607
Conditions
Study Description
Brief Summary: The aim of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to advanced kidney cancer.
Detailed Description: By enrolling patients with kidney cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of the combined therapy using cryosurgery and nature killer (NK) cells for advanced kidney cancer. The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).
Eligibility
Minimum Age: 30 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cancer Institute in Fuda cancer hospital, Guangzhou, Guangdong, China
Contact Details
Name: Guifeng Liu, PhD
Affiliation: Fuda Cancer Hospital, Guangzhou
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
